{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ullah J"],"funding":["Pakistan Academy of Sciences"],"pagination":["320-327"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8691035"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(1)"],"pubmed_abstract":["Left ventricular systolic dysfunction (LVSD) is common in patients with pre-existing ischemic heart disease (IHD) and myocardial infarction. An untargeted proteomic approach is used to improve the understanding of the molecular mechanisms associated with LVSD and to find out potential proteomic signatures in pericardial fluid. The pericardial fluid of IHD (<i>n</i> = 45) patients was grouped into two categories according to the left ventricular ejection fraction, LVEF ≥45 (<i>n</i> = 33) and LVEF <45 (<i>n</i> = 12), and analyzed by using nano-liquid chromatography-mass spectrometry (nano-LC-MS/MS) technique. The nano-LC-MS/MS analysis resulted in the identification of 709 pericardial fluid (PF) proteins in both normal and impaired systolic functional groups (LVEF ≥45 <i>vs.</i> LVEF <45)."],"journal":["RSC advances"],"pubmed_title":["Pericardial fluid proteomic label-free quantification of differentially expressed proteins in ischemic heart disease patients with systolic dysfunction by nano-LC-ESI-MS/MS analysis."],"pmcid":["PMC8691035"],"funding_grant_id":["Grant # 5-9/PAS/745"],"pubmed_authors":["El-Seedi HR","Khan F","Hashmi S","Ali A","Ullah J","Basir N","Sharif H","Musharraf SG","Sami SA","Bokhari SS"],"additional_accession":[]},"is_claimable":false,"name":"Pericardial fluid proteomic label-free quantification of differentially expressed proteins in ischemic heart disease patients with systolic dysfunction by nano-LC-ESI-MS/MS analysis.","description":"Left ventricular systolic dysfunction (LVSD) is common in patients with pre-existing ischemic heart disease (IHD) and myocardial infarction. An untargeted proteomic approach is used to improve the understanding of the molecular mechanisms associated with LVSD and to find out potential proteomic signatures in pericardial fluid. The pericardial fluid of IHD (<i>n</i> = 45) patients was grouped into two categories according to the left ventricular ejection fraction, LVEF ≥45 (<i>n</i> = 33) and LVEF <45 (<i>n</i> = 12), and analyzed by using nano-liquid chromatography-mass spectrometry (nano-LC-MS/MS) technique. The nano-LC-MS/MS analysis resulted in the identification of 709 pericardial fluid (PF) proteins in both normal and impaired systolic functional groups (LVEF ≥45 <i>vs.</i> LVEF <45).","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Dec","modification":"2026-05-31T11:18:55.729Z","creation":"2025-04-06T09:05:21.875Z"},"accession":"S-EPMC8691035","cross_references":{"pubmed":["35423047"],"doi":["10.1039/d0ra08389e"]}}